TABLE 7

Logistic Regression of Outcome Improvement Across 7 Months on Baseline PSQ Scale and AHI

No. (%) of Participants With Improvement From BaselineaOR (95% CI)P
Higher NEPSY-AE91 (50%)
 PSQ1.02 (0.75–1.38).91
 AHI1.08 (0.89–1.47).61
Lower BRIEF64 (35%)
 PSQ1.45 (1.04–2.02).03
 AHI1.14 (0.82–1.57).44
Lower Connors54 (30%)
 PSQ1.57 (1.11–2.23).01
 AHI1.01 (0.71–1.42).97
Lower CBCL79 (44%)
 PSQ1.58 (1.13–2.21).008
 AHI1.01 (0.73–1.40).95
Higher PedsQL (child)73 (40%)
 PSQ1.27 (0.82–1.97).29
 AHI0.66 (0.39–1.11).11
Higher PedsQL (parent)66 (36%)
 PSQ1.69 (1.09–2.60).02
 AHI0.89 (0.57–1.41).63
Lower OSAS-18147 (81%)
 PSQ2.16 (1.38–3.38).0008
 AHI1.10 (0.72–1.67).67
Lower ESS82 (44%)
 PSQ1.72 (1.24–2.38).001
 AHI1.05 (0.77–1.43).77
  • Logistic regression adjusted for age, gender, race, BMI z score. PSG and AHI normalized to reflect the effect of a 1 SD increase (equivalent to 0.18 points on the PSQ or 5.8 points in the AHI), after adjustment for the baseline value of the other predictor and other covariates in the model.

  • a Clinically meaningful improvement defined as an improvement in the morbidity measure by ≥0.5 SD from its baseline mean.